1. Home
  2. BRBS vs DCTH Comparison

BRBS vs DCTH Comparison

Compare BRBS & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRBS

Blue Ridge Bankshares Inc.

HOLD

Current Price

$4.35

Market Cap

394.3M

Sector

Finance

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.09

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRBS
DCTH
Founded
1893
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.3M
350.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BRBS
DCTH
Price
$4.35
$10.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$22.60
AVG Volume (30 Days)
220.8K
505.9K
Earning Date
01-29-2026
11-04-2025
Dividend Yield
5.75%
N/A
EPS Growth
N/A
N/A
EPS
0.05
0.03
Revenue
$96,332,000.00
$79,603,000.00
Revenue This Year
N/A
$131.69
Revenue Next Year
N/A
$39.22
P/E Ratio
$83.34
$295.89
Revenue Growth
N/A
251.54
52 Week Low
$2.92
$8.12
52 Week High
$4.79
$18.23

Technical Indicators

Market Signals
Indicator
BRBS
DCTH
Relative Strength Index (RSI) 48.34 50.02
Support Level $4.24 $9.69
Resistance Level $4.40 $10.86
Average True Range (ATR) 0.12 0.35
MACD -0.01 -0.01
Stochastic Oscillator 38.37 29.06

Price Performance

Historical Comparison
BRBS
DCTH

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: